CompletedPhase 2Phase 3ACTRN12608000619347

Chinese herbs in the treatment of laparoscopy diagnosed endometriosis: a controlled study.

A randomised double-blind placebo controlled clinical trial of the use of Chinese herbal medicine in the management of endometriosis.


Sponsor

University of Western Sydney

Enrollment

150 participants

Start Date

Jun 1, 2004

Study Type

Interventional

Conditions

Summary

The study is a randomised, double-blind, multi-centre clinical trial to evaluate the use of Chinese herbal medicine in the management of endometriosis. Formulated Chinese herbs will be assessed against an inert placebo. Trial participants will be randomly allocated to either Chinese herbal medicine or placebo. Neither participants nor researchers/assessors will have knowledge of the allocation. It is a prospective clinical study in which participants are reviewed monthly for six months, and three month follow up. Stringent methodology includes an objective laparoscopy diagnosis of endometriosis and suitable outcome measures. The study also includes ensuring participants completing the trial and, facilitating consistent data collection and validity. The trial will be a multi-centre clinical trial with participants recruited and reviewed at several health centres. This will be the first clinical trial in Australia combining Chinese herbal medicine, an objective diagnosis (laparoscopy) and a strict methodological protocol.


Eligibility

Sex: FemalesMin Age: 18 YearssMax Age: 43 Yearss

Plain Language Summary

Simplified for easier understanding

This study is for women aged 18 to 43 who have been diagnosed with endometriosis through laparoscopy and have experienced pain for at least 3 months or had surgery for endometriosis in the last 6 months. It investigates whether Chinese herbal medicine can help manage endometriosis symptoms compared to standard care.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Chinese herbal medicine extract in oral capsule form, with a dosage of 4 capsules twice daily for six months. The formulation ingredients remain commercial-in-confidence.

Chinese herbal medicine extract in oral capsule form, with a dosage of 4 capsules twice daily for six months. The formulation ingredients remain commercial-in-confidence.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000619347


Related Trials